BTC Antibodies

Santa Cruz Biotechnology features a diverse variety of BTC Antibodies for investigating BTC protein functions. BTC Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BTC protein, also known as the B-cell activating factor, plays a crucial role in the regulation of B-cell development and function. It is essential for the survival and proliferation of B-cells, making it a key player in the immune response. Understanding BTC mechanisms can provide insights into various immunological disorders and potential therapeutic targets. BTC research continues to reveal new aspects of B-cell biology and immune system regulation. Investigating BTC signaling pathways helps illuminate complex immune responses and their impact on human health. Current research focuses on understanding how BTC influences B-cell homeostasis and immune system maintenance. Santa Cruz Biotechnology monoclonal antibodies for BTC support researchers worldwide in advancing immunological discoveries and developing new therapeutic strategies.